Comparing the Infectious and Neoplastic Adverse Event Profiles of Ocrelizumab and Cladribine Using the FDA Adverse Event Reporting Database (P9-6.009) Nasrin Rahimian,Olaf Stuve,Afsaneh ShiraniNeurology（2024）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
